Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M53,104Revenue (TTM) $M9,306Net Margin (%)1.1Altman Z-Score1.1
Enterprise Value $M75,428EPS (TTM) $1.6Operating Margin %5.7Piotroski F-Score5
P/E(ttm)144Beneish M-Score-1.6Pre-tax Margin (%)1.9Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsY
Price/Sales4.95-y EBITDA Growth Rate %20.7Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-32.1ROA % (ttm)0.3Higher Current Ratio y-yY
Dividend Yield %0.5PEG3.9ROE % (ttm)0.6Less Shares Outstanding y-yN
Payout Ratio %41.0Shares Outstanding M301ROIC % (ttm)3.3Gross Margin Increase y-yN

Gurus Latest Trades with SHPG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SHPGJulian Robertson 2016-09-30 Reduce-2.52%$185.2 - $206.56
($195.06)
$ 176.39-10%Reduce -35.17%78,154
SHPGJohn Paulson 2016-09-30 Reduce-1.01%$185.2 - $206.56
($195.06)
$ 176.39-10%Reduce -10.14%4,667,800
SHPGLeon Cooperman 2016-09-30 Add0.91%$185.2 - $206.56
($195.06)
$ 176.39-10%Add 74.66%356,484
SHPGSteve Mandel 2016-09-30 Reduce-0.71%$185.2 - $206.56
($195.06)
$ 176.39-10%Reduce -32.99%1,694,675
SHPGThird Avenue Management 2016-09-30 Add0.18%$185.2 - $206.56
($195.06)
$ 176.39-10%Add 42.61%68,224
SHPGKen Fisher 2016-09-30 Add0.04%$185.2 - $206.56
($195.06)
$ 176.39-10%Add 276.87%166,168
SHPGTweedy Browne 2016-09-30 Reduce-0.03%$185.2 - $206.56
($195.06)
$ 176.39-10%Reduce -14.07%36,304
SHPGMario Gabelli 2016-09-30 Reduce-0.01%$185.2 - $206.56
($195.06)
$ 176.39-10%Reduce -78.86%1,242
SHPGFirst Eagle Investment 2016-09-30 Reduce$185.2 - $206.56
($195.06)
$ 176.39-10%Reduce -6.21%53,037
SHPGDavid Dreman 2016-09-30 Reduce$185.2 - $206.56
($195.06)
$ 176.39-10%Reduce -4.29%134
SHPGKeeley Asset Management Corp 2016-09-30 Reduce$185.2 - $206.56
($195.06)
$ 176.39-10%Reduce -2.26%17,322
SHPGMartin Whitman 2016-07-31 Buy 0.73%$164.64 - $195.43
($183.69)
$ 176.39-4%New holding42,138
SHPGJulian Robertson 2016-06-30 Buy 7.16%$164.64 - $192.14
($180.43)
$ 176.39-2%New holding120,554
SHPGJohn Paulson 2016-06-30 Reduce-2.44%$164.64 - $192.14
($180.43)
$ 176.39-2%Reduce -26.54%5,194,600
SHPGSteve Mandel 2016-06-30 Buy 2.15%$164.64 - $192.14
($180.43)
$ 176.39-2%New holding2,529,148
SHPGLeon Cooperman 2016-06-30 Buy 1.06%$164.64 - $192.14
($180.43)
$ 176.39-2%New holding204,100
SHPGThird Avenue Management 2016-06-30 Buy 0.39%$164.64 - $192.14
($180.43)
$ 176.39-2%New holding47,840
SHPGTweedy Browne 2016-06-30 Buy 0.22%$164.64 - $192.14
($180.43)
$ 176.39-2%New holding42,247
SHPGKeeley Asset Management Corp 2016-06-30 Buy 0.14%$164.64 - $192.14
($180.43)
$ 176.39-2%New holding17,723
SHPGMario Gabelli 2016-06-30 Buy 0.01%$164.64 - $192.14
($180.43)
$ 176.39-2%New holding5,874
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SHPG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SHPG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about SHPG:

News about SHPG:

Articles On GuruFocus.com
John Paulson's Largest 3rd Quarter Trades Dec 01 2016 
Momenta Pharmaceuticals Announces Positive Results for Humira Biosimilar Nov 30 2016 
Samuel Isaly Makes 9 New Buys in 3rd Quarter Nov 04 2016 
Martin Whitman's Top Recent Investments Oct 12 2016 
John Paulson’s Health Care Picks Plunge in Flat Year for Sector Oct 06 2016 
Whitman's Third Avenue Buys 3 Pharma Stocks in 3rd Quarter Sep 27 2016 
Mairs and Power Buys Walt Disney, Exits Baxalta Sep 27 2016 
Third Avenue Value Fund 3rd Quarter Letter Sep 14 2016 
Hedge Funds Love Liberty and John Malone Aug 26 2016 
Steve Mandel Buys Shire, Axes 6 Positions in 2nd Quarter Aug 17 2016 

More From Other Websites
Blog Coverage Shire Announced Successful Results of its Phase III Investigational Study of... Dec 05 2016
Better buy: GlaxoSmithKline plc vs Shire plc Dec 05 2016
5 Healthcare Stocks Billionaires Love The Most Dec 04 2016
5:23 pm Shire plc revealed new in vitro data showing potential for excessive thrombin generation... Dec 04 2016
Shire Reports on Four Decades of Real-World Safety Experience With FEIBA® Dec 02 2016
Shire Loses Ground To Allergan In Thanksgiving Week Dry-Eye Scripts Dec 02 2016
SHIRE PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Dec 02 2016
Topline Results of Phase 3 Investigational Study of VONVENDI™ Meets Primary Endpoint Effectively... Dec 02 2016
Coverage initiated on Shire plc by Societe Generale Dec 02 2016
John Paulson's Largest 3rd Quarter Trades Dec 01 2016
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Dec 01 2016
Is Smart Money Turning More Positive on Bed Bath & Beyond Inc. (BBBY)? Dec 01 2016
Total Voting Rights Dec 01 2016
What Does Smart Money Think about Avery Dennison Corp (AVY)? Dec 01 2016
Momenta/Shire's Humira Biosimilar Meets Study Objective Nov 30 2016
Momenta stock jumps nearly 10% on positive late-stage results for Humira biosimilar Nov 29 2016
Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan Nov 28 2016
5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy Nov 28 2016
Do Hedge Funds Love PulteGroup, Inc. (PHM)? Nov 24 2016
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Nov 23 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)